Skip to main content

Table 2 Association result for the HP duplication with measures of subclinical CVD and blood lipids

From: Genetic analysis of haptoglobin polymorphisms with cardiovascular disease and type 2 diabetes in the diabetes heart study

HP Duplication – CVD Association Results

 

Additive

Dominant

Recessive

 

N

Beta ± SE

p-value

Beta ± SE

p-value

Beta ± SE

p-value

CAC

1134

0.022±0.097

0.82

−0.025±0.135

0.85

0.135±0.189

0.48

CarCP

1142

−0.159±0.102

0.12

−0.180±0.142

0.21

−0.255±0.200

0.20

AACP

865

−0.025±0.102

0.81

−0.117±0.141

0.41

0.141±0.202

0.48

IMT

1103

−0.008±0.003

0.01

−0.014±0.004

0.001

−0.002±0.006

0.79

Cholesterol

1188

0.006±0.010

0.53

0.014±0.013

0.28

−0.005±0.019

0.78

Triglycerides

1188

0.060±0.024

0.01

0.091±0.033

0.005

0.050±0.047

0.28

Prevalent CVD

1084

−0.033 ± 0.061

0.58

0.006 ± 0.083

0.94

−0.140 ± 0.117

0.23

All Cause Mortality

1208

0.063 ± 0.065

0.33

0.123 ± 0.089

0.17

−0.004 ± 0.129

0.98

CVD Mortality

1208

0.145 ± 0.081

0.07

0.222 ± 0.101

0.04

0.117 ± 0.116

0.47

  1. Associations were examined under additive, dominant and recessive genetic models. Bold indicates statistical significance. CAC: coronary artery calcified plaque; CarCP: carotid artery calcified plaque; AACP: abdominal aortic calcified plaque; IMT: carotid intima-media thickness. SE = standard error.